These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis]. Tang XJ, Zhou QH, Zhang SF, Liu LX. Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109 [Abstract] [Full Text] [Related]
7. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Yoshida R, Kimura N, Harada Y, Ohuchi N. Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480 [Abstract] [Full Text] [Related]
14. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Boo YJ, Park JM, Kim J, Chae YS, Min BW, Um JW, Moon HY. Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730 [Abstract] [Full Text] [Related]
19. The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. Al-Saad S, Al-Shibli K, Donnem T, Persson M, Bremnes RM, Busund LT. Br J Cancer; 2008 Nov 04; 99(9):1476-83. PubMed ID: 18854838 [Abstract] [Full Text] [Related]
20. Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas. Kurtz KA, Hoffman HT, Zimmerman MB, Robinson RA. Otolaryngol Head Neck Surg; 2006 Jan 04; 134(1):142-6. PubMed ID: 16399195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]